197
Views
10
CrossRef citations to date
0
Altmetric
Original Articles

Fluticasone propionate–loaded solid lipid nanoparticles with augmented anti-inflammatory activity: optimisation, characterisation and pharmacodynamic evaluation on rats

, , , & ORCID Icon
Pages 177-191 | Received 16 Oct 2020, Accepted 04 Feb 2021, Published online: 17 Feb 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Saeed A. S. Al-Zuhairy, Mahmoud H. Teaima, Nabil A. Shoman, Mohamed Elasaly, Mohamed A. El-Nabarawi & Hossam S. El-Sawy. (2023) PEGylated Tween 80-functionalized chitosan-lipidic nano-vesicular hybrids for heightening nose-to-brain delivery and bioavailability of metoclopramide. Drug Delivery 30:1.
Read now
Tarun Virmani, Girish Kumar, Reshu Virmani, Ashwani Sharma & Kamla Pathak. (2022) Nanocarrier-Based Approaches to Combat Chronic Obstructive Pulmonary Disease. Nanomedicine 17:24, pages 1833-1854.
Read now

Articles from other publishers (8)

Khalid M. El-Say, Mohamed A. Megahed, Ahmed Abdalla, Hossam S. El-Sawy, Hassan Afify, Afaf A. Ramadan & Tarek A. Ahmed. (2024) P-gp inhibition and enhanced oral bioavailability of amikacin Sulfate: A novel approach using Thiolated Chito-PEGylated Lipidic Hybrids. International Journal of Pharmaceutics 658, pages 124200.
Crossref
Hanan Elimam, Hossam S. El-Sawy, Marwa A.A. Fayed, Sara H. Mahmoud, Riham O. Bakr, Rasha M. Saleh, Ahmed Mostafa & Mohamed F. Elshal. (2024) Antiviral potential of rosuvastatin and hesperidin in combination with favipiravir liposomal nanoformulations in targeting the main protease (Mpro) of SARS-CoV-2: Molecular docking, molecular dynamics and in-vitro studies. Journal of Drug Delivery Science and Technology, pages 105799.
Crossref
Khalid M. El-Say, Omar D. Al-hejaili, Hossam S. El-Sawy, Nabil A. Alhakamy, Fathy I. Abd-Allah, Martin K. Safo & Tarek A. Ahmed. (2023) Incorporating sodium deoxycholate endorsed the buccal administration of avanafil to heighten the bioavailability and duration of action. Drug Delivery and Translational Research 13:9, pages 2297-2314.
Crossref
Cemre Eroğlu, Genada Sinani & Zeynep Ulker. (2023) Current State of Lipid Nanoparticles (SLN and NLC) for Skin Applications. Current Pharmaceutical Design 29:21, pages 1632-1644.
Crossref
Raquel da Ana, Joel Fonseca, Jacek Karczewski, Amélia M. Silva, Aleksandra Zielińska & Eliana B. Souto. (2022) Lipid-Based Nanoparticulate Systems for the Ocular Delivery of Bioactives with Anti-Inflammatory Properties. International Journal of Molecular Sciences 23:20, pages 12102.
Crossref
Mohamed A. Megahed, Hossam S. El-Sawy, Ahmed M. Reda, Fathy I. Abd-Allah, Sherif K. Abu Elyazid, Ahmed E. Lila, Hatem R. Ismael & Khalid M. El-Say. (2022) Effect of nanovesicular surface-functionalization via chitosan and/or PEGylation on cytotoxicity of tamoxifen in induced-breast cancer model. Life Sciences 307, pages 120908.
Crossref
Mohammad H. Alyami, Eman Zmaily Dahmash, Dalia Khalil Ali, Hamad S. Alyami, Hussien AbdulKarim & Samar A. Alsudir. (2022) Novel Fluticasone Propionate and Salmeterol Fixed-Dose Combination Nano-Encapsulated Particles Using Polyamide Based on L-Lysine. Pharmaceuticals 15:3, pages 321.
Crossref
Khalid M. El-Say, Tarek A. Ahmed, Arwa H. Aljefri, Hossam S. El-Sawy, Reza Fassihi & Magid Abou-Gharbia. (2021) Oleic acid–reinforced PEGylated polymethacrylate transdermal film with enhanced antidyslipidemic activity and bioavailability of atorvastatin: A mechanistic ex-vivo/in-vivo analysis. International Journal of Pharmaceutics 608, pages 121057.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.